Skip to content

Lung Adenocarcinoma with AI Precise Diagnosis and Clinical Decision Assistant System based on CT: a Multi-Center Perspective Clinical Trial

Lung Adenocarcinoma with AI Precise Diagnosis and Clinical Decision Assistant System based on CT: a Multi-Center Perspective Clinical Trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000036248
Enrollment
Unknown
Registered
2020-08-22
Start date
2020-11-01
Completion date
Unknown
Last updated
2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Adenocarcinoma

Interventions

Gold Standard:Pathology, including surgery and biopsy
precision&#32
diagnosis&#32
and&#32
clinical&#32
system&#32

Sponsors

Shanghai Public Health Clinical Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: a. Excellent thin-slice CT image quality during plain scan (slice thickness = 2cm nodules shall not be less than 20% of the total number of cases. (2) Accurate diagnosis of lung adenocarcinoma subtypes: a. Postoperative pathological staging is T1N0M0; b. Preoperative CT of the chest showed ground-glass nodules (pure ground-glass nodules and mixed ground-glass nodules) (note: Lung adenocarcinomas with solid nodules, mostly IAC, are not included in the study); c. Preoperative chest CT showed that the maximum cross-sectional average diameter of the nodules was 1cm, but = 2cm nodules shall not be less than 30 %); c. The distance from the pleura is = 2cm nodules not less than 50% of the total number of cases. (5) Assess mediastinal and hilar lymph node metastasis: Underwent radical resection of lung cancer and lymph node dissection, pathology confirmed whether mediastinal and hilar lymph node metastasis. (6) Assessment of extrathoracic metastasis: After undergoing radical resection of lung cancer and lymph node dissection, surgery or puncture pathology will determine whether there is extrathoracic metastasis.

Exclusion criteria

Exclusion criteria: a. Obvious imaging artifacts; b. Respiratory motion artifacts; c. Low-dose CT images (single dose less than 1.5 mSv); d. Patients received radiotherapy and chemotherapy before surgery.

Design outcomes

Primary

MeasureTime frame
Diagnostic efficiency of CT-AI system;

Countries

China

Contacts

Public ContactFei Shan

Shanghai Public Health Clinical Center

shanfei@shphc.org.cn+86 18930818986

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026